ESPRIT IL-2: Evaluation of Subcutaneous Proleukin in a Randomized International Trial
ESPRIT is a randomized, international, 5-year, 4000-person study of interleukin-2 (IL-2) in people with HIV infection and a CD4+ (also called T4) cell count of at least 300/mm3. The goal of study is to evaluate and compare the effectiveness of IL-2 plus a
Is this your site? Certify your site and update informations
